Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Rabies Vaccine Market 2018, Forecast to 2023
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
Scope of the Report:
This report focuses on the Rabies Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Every year more than 5.5 million people have died for rabies, mostly in Asia and Africa. With the implementation of China's two-child policy, downstream demand for rabies vaccine will not decrease in the coming few years.
Rabies vaccine is an irreplaceable product, so profile of rabies vaccine is very large. But due to its security requirements than the general drugs, the entire vaccine industry from R & D, production to distribution, sales and after-sales feedback link subject to very strict regulation. So, production companies are not as much as we imagined.
The most wildly used rabies vaccine is Vero cell rabies vaccine (VRV), which takes about 80.85% in 2016.
Nowadays, global rabies vaccine production is mainly concentrated in China, Europe and North America. In 2016, China rabies vaccine production takes about 74.34% and Europe production takes about 7.46%.
The worldwide market for Rabies Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Vero Cell Rabies Vaccine
Chick Embryo Cell Rabies Vaccine
Market Segment by Applications, can be divided into
There are 15 Chapters to deeply display the global Rabies Vaccine market.
Chapter 1, to describe Rabies Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Rabies Vaccine, with sales, revenue, and price of Rabies Vaccine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Rabies Vaccine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Rabies Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Rabies Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook